Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma

Sven H. Loosen, Fabian Benz, Jennifer Niedeggen, Maximilian Schmeding, Florian Schueller, Alexander Koch, Mihael Vucur, Frank Tacke, Christian Trautwein, Christoph Roderburg, Ulf P. Neumann, Tom Luedde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number39
JournalClinical and Translational Medicine
Volume5
Issue number1
DOIs
Publication statusPublished - 27 Sep 2016

Keywords

  • S100A6
  • Cholangiocarcinoma (CCA)
  • Cancer
  • Biomarker
  • Prognosis
  • CA19-9
  • CEA

Cite this

Loosen, S. H., Benz, F., Niedeggen, J., Schmeding, M., Schueller, F., Koch, A., Vucur, M., Tacke, F., Trautwein, C., Roderburg, C., Neumann, U. P., & Luedde, T. (2016). Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma. Clinical and Translational Medicine, 5(1), [39]. https://doi.org/10.1186/s40169-016-0120-7